Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ANN C HENDERSON TILTON

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology with Special Qualifications in Child Neurology

NPI
1760405609
CMS profile
840270
Location
NEW ORLEANS, LA

General Payments · PY2018–2024

$115,156.84

  • Reported across 260 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$31,141.22

29 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $15,470.64 44
PY2019 $13,218.94 54
PY2020 $10,509.21 21
PY2021 $14,038.29 33
PY2022 $16,970.50 41
PY2023 $13,808.04 38
PY2024 $31,141.22 29

Payment records · PY2024 (29)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $1,200.00 04/01/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1103154036 CMS
ACADIA Pharmaceuticals Inc $19.84 08/14/2024 Food and Beverage Undisputed 01/23/2026 1147974783 CMS
ARGENX US, INC. $121.83 11/21/2024 Food and Beverage Undisputed 01/23/2026 1142120817 CMS
Biogen, Inc. $77.49 06/07/2024 Education Undisputed 01/23/2026 1104812179 CMS
Biogen, Inc. $22.22 07/10/2024 Food and Beverage Undisputed 01/23/2026 1104824494 CMS
CATALYST PHARMACEUTICALS, INC. $34.81 06/03/2024 Food and Beverage Undisputed 01/23/2026 1144457261 CMS
CATALYST PHARMACEUTICALS, INC. $33.52 11/20/2024 Food and Beverage Undisputed 01/23/2026 1144445262 CMS
Genentech USA, Inc. $18.75 05/01/2024 Food and Beverage Undisputed 01/23/2026 1132977367 CMS
Ipsen Biopharmaceuticals, Inc $302.16 02/10/2024 Travel and Lodging Undisputed 01/23/2026 1091951579 CMS
Ipsen Biopharmaceuticals, Inc $359.44 02/10/2024 Travel and Lodging Undisputed 01/23/2026 1091951581 CMS
Ipsen Biopharmaceuticals, Inc $14,250.00 02/10/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1091951583 CMS
Ipsen Biopharmaceuticals, Inc $634.98 02/10/2024 Food and Beverage Undisputed 01/23/2026 1091951585 CMS
Ipsen Biopharmaceuticals, Inc $848.76 02/10/2024 Travel and Lodging Undisputed 01/23/2026 1091951587 CMS
Ipsen Biopharmaceuticals, Inc $24.83 04/25/2024 Food and Beverage Undisputed 01/23/2026 1091951593 CMS
Ipsen Biopharmaceuticals, Inc $92.69 05/16/2024 Food and Beverage Undisputed 01/23/2026 1091951597 CMS
Ipsen Biopharmaceuticals, Inc $1,125.00 05/17/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1091951595 CMS
Ipsen Biopharmaceuticals, Inc $4,500.00 08/22/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1091951575 CMS
Ipsen Biopharmaceuticals, Inc $126.30 08/22/2024 Food and Beverage Undisputed 01/23/2026 1091951577 CMS
Ipsen Biopharmaceuticals, Inc $146.70 09/11/2024 Food and Beverage Undisputed 01/23/2026 1091951589 CMS
Ipsen Biopharmaceuticals, Inc $5,250.00 09/11/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1091951591 CMS
Ipsen Biopharmaceuticals, Inc $139.08 09/11/2024 Travel and Lodging Undisputed 01/23/2026 1091951601 CMS
Ipsen Biopharmaceuticals, Inc $977.91 09/11/2024 Travel and Lodging Undisputed 01/23/2026 1091951603 CMS
Ipsen Biopharmaceuticals, Inc $658.91 09/11/2024 Travel and Lodging Undisputed 01/23/2026 1091951605 CMS
Ipsen Biopharmaceuticals, Inc $29.35 12/17/2024 Food and Beverage Undisputed 01/23/2026 1091951599 CMS
Neurelis, Inc. $29.31 01/17/2024 Food and Beverage Undisputed 01/23/2026 1145643322 CMS
Neurelis, Inc. $30.39 08/07/2024 Food and Beverage Undisputed 01/23/2026 1145643324 CMS
NS Pharma, Inc. $21.68 05/15/2024 Food and Beverage Undisputed 01/23/2026 1139459322 CMS
Sarepta Therapeutics, Inc. $29.39 06/27/2024 Food and Beverage Undisputed 01/23/2026 1126540733 CMS
UPSHER-SMITH LABORATORIES LLC $35.88 10/30/2024 Food and Beverage Undisputed 01/23/2026 1127356693 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.